Reps. Tout Bill Giving Generics Cos. Leg Up On Exclusivity

Law360, New York (April 4, 2012, 5:15 PM EDT) -- Newly proposed legislation would give generic-drug makers a boost when vying for market exclusivity by giving a patent challenger more time to win approval from the U.S. Food and Drug Administration, the bill's sponsors announced Tuesday.

Under current law, the first generics company to challenge a pharmaceutical patent can get 180 days of market exclusivity once their generic is approved — but only if the generic wins tentative approval from the FDA within 30 months.

But that deadline has become a problem, say the bill's sponsors...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.